Looking for answers?
Looking for answers?
Complete a quick but comprehensive set of questions, built by leading experts. It's the first step to your personalised hormone panel and a data-backed diagnosis for up to 18 conditions.

Anti-Mullerian Hormone (AMH) is one of the most talked-about markers in fertility and reproductive health. It is often described as a measure of ovarian reserve, which means the number of eggs remaining in the ovaries.
While much of the conversation focuses on low AMH, receiving a high result can raise its own set of questions. Does high AMH mean you are more fertile? Does it mean you have polycystic ovaries? Could it be linked to PMOS ( formerly known as PCOS)? And does having high AMH mean it will be easier to get pregnant?
The answer is more nuanced than a simple yes or no.
High AMH levels usually suggest that your ovaries contain a higher-than-expected number of small follicles for your age. This may be linked to polycystic ovaries, PMOS or natural variation. However, AMH does not measure egg quality, does not confirm whether you are ovulating regularly, and does not predict whether you will conceive naturally.
In this guide, we explain what high AMH levels mean for fertility, what causes it, how it relates to PCO and PMOS, what it can mean for IVF, and how Hertility interprets your AMH result as part of your wider hormone health.
If you haven’t yet tested your AMH, our Advanced At-Home Hormone & Fertility Test can measure AMH alongside up to nine other key hormones, giving you a personalised, clinically meaningful picture of your reproductive health.
Anti-Müllerian hormone (AMH) is a hormone made by small fluid-filled sacs in the ovaries called follicles, each of which contains an immature egg. Because AMH is made by these follicles, it gives an indication of how many eggs you have remaining at a given time. This is known as your ovarian reserve.
Ovarian reserve refers to egg quantity, not egg quality. This distinction is important. AMH can help estimate the number of eggs remaining, but it cannot tell you whether those eggs are genetically healthy, whether they will fertilise, or whether they will develop into a viable pregnancy.
Unlike hormones such as FSH, oestradiol, and LH, which fluctuate significantly across the menstrual cycle, AMH remains relatively stable. This means it can usually be measured at any point in the cycle and still provide useful information. However, recent studies have shown that there may be some slight variation in AMH levels across the menstrual cycle, but this variation remains considerably smaller than that seen in other reproductive hormones. As a result it is still considered one of the most stable and reliable markers of ovarian reserve.
It is also routinely used when someone is considering undergoing a fertility treatment to estimate how the ovaries are likely to respond to fertility medication, guide medication dosage, and inform treatment planning.
For a deeper dive into everything AMH testing can and can’t tell you, including its role in identifying PMOS and guiding fertility treatment, read our full guide: What Does AMH Testing Tell You? 5 Key Insights About Your Fertility
When we refer to “high AMH,” we mean a result that falls above the expected range for your age group. Because AMH naturally declines as you get older, what counts as “high” is always interpreted relative to age-specific reference ranges, not a single universal cutoff.
A high result suggests that your ovaries contain a larger-than-expected number of small follicles for someone your age. In practical terms, this means there is more AMH being made and circulating in the bloodstream. In isolation, this is not harmful, but is a signal worth investigating further, as it is closely associated with certain hormonal and reproductive health conditions.
This is the most common and potentially most consequential misconception about high AMH results. A high result can feel like good news, more eggs must mean better fertility, right? In fact, this is not necessarily true. High AMH levels are not automatically good or bad for fertility.
AMH tells you about egg quantity. It does not tell you anything about egg quality, that is, how healthy those eggs are, how likely they are to be fertilised, or how likely they are to develop into a viable embryo. Egg quality is influenced primarily by age and genetics, and there is currently no reliable way to measure it directly outside of assessing embryos created during IVF.
Beyond egg quality, fertility depends on many factors that AMH cannot assess at all; whether you are ovulating regularly, the health of your fallopian tubes and uterus, and sperm health. A high result offers no reassurance about any of these.
In short: a high AMH result does not predict your ability to conceive naturally, and should not delay seeking help if you have concerns about conceiving.
A high AMH result reflects a greater number of small follicles in the ovaries than would be expected for your age. The most common reasons for this include:
Unlike low AMH, a high result is not associated with previous surgery, cancer treatment, or lifestyle factors. In the vast majority of cases, the underlying explanation is PCO, PMOS, or natural variation, and your full hormone panel and clinical history will help clarify which.
PCO is a common reproductive health condition affecting around 30% of people with ovaries of reproductive age. It is characterised by a higher-than-expected number of small, immature follicles in the ovaries, which is precisely why AMH levels tend to be elevated in people with PCO. More follicles indicates more AMH being produced.
Importantly, PCO on its own is benign. It does not affect fertility and does not cause symptoms in most people. It is often identified incidentally, during an ultrasound, or increasingly, through a high AMH result.
<p>Because AMH is so closely associated with follicle count, updated clinical guidelines now allow AMH to be used as an indicator of polycystic ovaries in place of an ultrasound scan for the purposes of PMOS (formerly PCOS) diagnosis. However, at Hertility, we always recommend a pelvic ultrasound to further assess the ovaries, confirm the antral follicle count (AFC), and rule out other possible causes.
PMOS is a hormonal condition that can, but does not always, occur alongside PCO. It is one of the most common reproductive health conditions, affecting approximately 1 in 8 people with ovaries. Unlike PCO, PMOS (formerly PCOS) does not have a wider impact on health and can affect fertility, primarily by disrupting ovulation.
PMOS is diagnosed using criteria that may include irregular or absent periods, elevated androgens (such as testosterone), and the presence of polycystic ovaries on ultrasound or a high AMH. Common symptoms include irregular cycles, acne, unwanted hair growth, hair thinning, and weight changes, although not everyone with PMOS experiences all of these.
A high AMH result is not sufficient on its own to diagnose PMOS. Diagnosis requires a clinical assessment, including symptom history, hormone testing, and typically a pelvic ultrasound. If your AMH is high and you have symptoms that may suggest PMOS, we recommend speaking to a clinician for a full evaluation.
It is also important to note that many people with PMOS conceive naturally, and having PMOS does not mean you cannot get pregnant. The primary fertility impact of PMOS is on ovulation, which can be irregular or absent, but this can often be addressed with appropriate clinical support.
In people with PMOS, AMH levels can be significantly elevated, sometimes several times above the typical range. While this reflects the high number of follicles present, it is important to understand that many of these follicles are immature and unlikely to release eggs. This means that in the context of PMOS, AMH may substantially overestimate functional ovarian reserve, that is, the number of eggs that are actually available for fertilisation.
Similarly, the relationship between AMH and AFC (measured on ultrasound) can be less consistent in people with PMOS than in those without. This is one of the reasons why AMH should always be interpreted alongside other hormones and clinical findings, never in isolation.
One of the most important things to understand about a high result is what it cannot tell you, and the most significant of these is your ability to conceive naturally.
Current NICE guidelines (NG257, 2026) is explicit on the point: AMH should not be used as a predictor of clinical pregnancy through spontaneous conception. This applies in both directions. Just as low AMH does not mean you cannot conceive, a high AMH does not mean you will. The two things are simply not the same measurement.
A high AMH result offers no protection against age-related fertility decline. Delaying conception or delaying fertility investigations on the basis of a reassuring AMH result is not supported by the evidence, and current clinical guidance is clear that AMH should not be used in this way.
A high AMH result is not a prediction of easy conception, and should not delay seeking help if you have concerns.
In a fertility treatment context, AMH plays an important role in planning . A high AMH level suggests ovaries are likely to produce a strong response to stimulation medication during IVF, meaning more eggs may be retrieved. In principle, more eggs gives more embryos to work with, which can improve the cumulative chances of success.
However, a strong ovarian response also carries risk. The most significant concern is ovarian hyperstimulation syndrome (OHSS), a condition in which the ovaries overrespond to stimulation medication, becoming enlarged and causing fluid to accumulate in the body [13]. In its severe form, OHSS can be life threatening, though this is rare. Symptoms can include bloating, abdominal pain, nausea, and in more serious cases, difficulty breathing. Because of this risk, a high AMH result is an important signal for IVF treatment. It informs decisions about the type and dose of stimulation protocol used, and may mean a more cautious lower-dose approach to reduce OHSS risk. In some cases, a freeze-all strategy may be advised, where all embryos are frozen after retrieval and transferred in a later, unstimulated cycle, further reducing risk.
If you are considering IVF and have a high AMH result, your clinical team will use this information, along with your AFC, age, and overall health, to tailor your protocol. A high AMH is not a barrier to IVF; it simply means your treatment needs to be carefully planned.
If you are currently using hormonal contraception, it is worth knowing that this may affect your AMH result, though this is more relevant in cases of low AMH.
Research suggests that some forms of contraception, in particular the combined oral contraceptive pill (COCP), can temporarily suppress AMH levels by approximately 20-30%. This means that if you’re using hormonal contraception, your AMH result may be lower than your true baseline, and if your suppressed result is already above range, your actual level may be higher still.
This suppression is temporary and reversible. Levels typically return to what is normal for your individual after stopping contraception. For the most accurate reflection of your baseline AMH, we recommend waiting approximately three months after stopping hormonal contraception before testing, to allow your natural hormonal patterns to re-establish.
At Hertility, we do still include AMH testing for people using hormonal contraception, as even a suppressed result can provide clinically useful information, including identifying patterns consistent with PCO or PMOS. You can read more about testing your hormones on contraception here.
If you have a high AMH result and are trying to conceive, the most important thing to know is that a high result does not make conception any easier or more likely than it would otherwise be.
If you have a high AMH alongside symptoms of PMOS, such as irregular periods, which may indicate irregular or absent ovulation. This is worth exploring further with a clinician. Ovulation is one of the most important prerequisites for natural conception, and irregular ovulation is the primary fertility challenge associated with PMOS. The good news is that this is a well-understood area of reproductive medicine with established treatment options, read our blog on trying to conceive with PCOS for more information.
If you have a high AMH but no symptoms and regular cycles, the clinical picture is different, but a high AMH alone is not a reason to delay seeking help if you have been trying to conceive for 12 months (or 6 months if you are 35 or over) without success.
If you have concerns about your AMH result and what it means for your fertility, booking a Clinical Reproductive Care Consultation is a good next step. This consultation is built around your Hertility test results, allowing our clinical team to provide context and clarity and guide your next steps in a personalised way.
This is also directly supported by current NICE guidelines, which explicitly states that AMH should not be used as a predictor of clinical pregnancy through spontaneous conception, which applies to both directions. A high AMH is no more a predictor of easy natural conception than a low AMH is a predictor of difficulty.
At Hertility, we use age-stratified reference ranges to interpret your AMH results. This means your result is not compared to a single cutoff, but against the expected range for other healthy individuals in your age group.
These reference ranges are derived from published population data and clinical evidence, and are reviewed to ensure they reflect current scientific evidence. Interpreting AMH in this way allows us to give you a more accurate and contextually meaningful result, rather than labelling a result as being “low” when it may reflect normal reproductive ageing for your stage in life.
We believe everyone deserves access to clear, evidence-based information about their reproductive health, without having to wait until an issue arises.
Our Advanced At-Home Hormone & Fertility Test measures AMH alongside up to nine other key hormones, and your results are interpreted by our clinical team in the context of your individual online health assessment (OHA) our clinically validated screening tool that embeds the diagnostic criteria from leading international bodies including RCOG, ASRM, ACOG, ESHRE, and NICE to assess risk of fertility decline and screen for 18 of the most prevalent conditions affecting reproductive health.
The OHA captures your symptoms, biometrics, menstrual factors, and life stage to enable a tailored hormone panel, the combination most likely to be informative for you specifically, and able to confirm any suspected diagnoses. Rather than simply telling you whether your AMH is “high,” “normal,” or “low,” this approach means your result is always interpreted with full clinical context.
Because no single hormone tells the whole story, your AMH result is also never assessed in isolation. At Hertility, it is interpreted alongside up to nine other reproductive hormones, including FSH, LH, oestradiol, testosterone, prolactin and thyroid hormones, as well as a detailed clinical history. This allows us to screen for up to 18 reproductive and hormonal health conditions and provide a truly personalised assessment.
Does high AMH mean I’m more fertile or that conception will be easier?
No. Current NICE guidance explicitly states that AMH should not be used as a predictor of clinical pregnancy through spontaneous conception. A high AMH indicates a higher-than-expected number of follicles, but it does not tell you anything about egg quality, whether you are ovulating, or any of the other factors that determine whether you can conceive naturally. AMH in either direction is not a reliable predictor of natural pregnancy rates.
High AMH usually means your ovaries contain a higher-than-expected number of small follicles for your age. It can be linked to polycystic ovaries or PMOS, formerly PCOS, but it can also reflect natural variation.
High AMH is not automatically good or bad. It can suggest a higher ovarian reserve, but it does not measure egg quality or predict natural conception. It may also indicate an underlying health condition such as PCO or PMOS, formerly PCOS.
High AMH can support an assessment for PMOS but it does not diagnose the condition on its own. A diagnosis needs clinical assessment, symptom history, androgen hormone testing and sometimes a pelvic ultrasound scan.
High AMH itself does not usually cause infertility. However, if high AMH relates to PMOS and irregular ovulation, it may make conception harder. Many people with high AMH or PMOS still conceive naturally.
No. AMH measures egg quantity, not egg quality. Age and genetics influence egg quality much more strongly than AMH.
Yes. Some hormonal contraception may temporarily lower AMH. This effect usually reverses after stopping contraception. Hertility can still test AMH while you use contraception, but we interpret the result in context.
References:
[1] Cleveland Clinic, Diagnostics, Anti-Mullerian Hormone Test, https://my.clevelandclinic.org/health/diagnostics/22681-anti-mullerian-hormone-test
[2] Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407(10545):2329-2339. doi:10.1016/S0140-6736(26)00717-8
[3] Marcelle I Cedars, Evaluation of Female Fertility—AMH and Ovarian Reserve Testing, The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 6, June 2022, Pages 1510–1519, https://doi.org/10.1210/clinem/dgac039
[4] Helena J Teede, Chau Thien Tay, Joop J E Laven, Anuja Dokras, Lisa J Moran, Terhi T Piltonen, Michael F Costello, Jacky Boivin, Leanne M Redman, Jacqueline A Boyle, Robert J Norman, Aya Mousa, Anju E Joham, the International PCOS Network , Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome, European Journal of Endocrinology, Volume 189, Issue 2, August 2023, Pages G43–G64, https://doi.org/10.1093/ejendo/lvad096
[5] Muharam R, Prasetyo YD, Prabowo KA, Putri YI, Maidarti M, Hestiantoro A. IVF outcome with a high level of AMH: a focus on PCOS versus non-PCOS. BMC Womens Health. 2022;22(1):172. Published 2022 May 14. doi:10.1186/s12905-022-01756-4
[6] Ran Y, Yi Q, Li C. The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups. Diabetes Metab Syndr Obes. 2021;14:1419-1424. Published 2021 Mar 25. doi:10.2147/DMSO.S299558
[7] Shebl O, Ebner T, Sir A, Schreier-Lechner E, Mayer R. B, Tews G, Sommergruber M, Age-related distribution of basal serum AMH level in women of reproductive age and a presumably healthy cohort Fertility and Sterility, 2010; 95, 832-834
[8] Pellatt L, Hanna L, Brincat M, et al. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92(1):240-245. doi:10.1210/jc.2006-1582
[9] Fertility problems: assessment and treatment · NICE guideline · Reference number: NG257 · Published: 31 March 2026 https://www.nice.org.uk/guidance/ng257/chapter/Investigation-of-fertility-problems-and-management-strategies
[10] Lin C, Jing M, Zhu W, et al. The Value of Anti-Müllerian Hormone in the Prediction of Spontaneous Pregnancy: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021;12:695157. Published 2021 Oct 13. doi:10.3389/fendo.2021.695157
[11] Moghadam ARE, Moghadam MT, Hemadi M, Saki G. Oocyte quality and aging. JBRA Assist Reprod. 2022;26(1):105-122. Published 2022 Jan 17. doi:10.5935/1518-0557.20210026
[12] Gomez, R., Schorsch, M., Hahn, T. et al. The influence of AMH on IVF success. Arch Gynecol Obstet 293, 667–673 (2016). https://doi.org/10.1007/s00404-015-3901-0
[13] Cleveland Clinic, Ovarian Hyperstimulation Syndrome, OHSS https://my.clevelandclinic.org/health/diseases/17972-ovarian-hyperstimulation-syndrome-ohss
[14] Landersoe SK, Forman JL, Birch Petersen K, et al. Ovarian reserve markers in women using various hormonal contraceptives. Eur J Contracept Reprod Health Care. 2020;25(1):65-71. doi:10.1080/13625187.2019.1702158[15] Hariton E, Shirazi T, Douglas N, Hershlag A, Sharon F. Briggs S F, PhD
Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals
American Journal of Obstetrics & Gynecology, 2021; 225, 515.e1-515.e10
Looking for answers?